Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
Dis Colon Rectum ; 67(S1): S115-S124, 2024 Jun 01.
Article in English | MEDLINE | ID: mdl-38422401

ABSTRACT

BACKGROUND: Restorative proctocolectomy and IPAA have become the surgical procedure of choice in pediatric patients with medically refractory colitis or familial adenomatous polyposis. OBJECTIVE: This systematic review aims to assess the diagnosis and treatment of pouch disorders in pediatric patients who undergo IPAA. DATA SOURCES: A literature search was performed using MEDLINE, Google Scholar, and Embase for all publications describing outcomes of pediatric IPAA. STUDY SELECTION: Studies between January 1, 2000, and September 7, 2022, published in English were included. Studies were excluded on the basis of title, abstract, and full-length review. INTERVENTIONS: IPAA. MAIN OUTCOME MEASURES: Pouch disorders described include anastomotic leaks, pouch strictures, pouch failure, pouchitis, cuffitis, and de novo Crohn's disease of the pouch. RESULTS: Thirty-three studies were included in this review, all of which were retrospective in nature. The outcomes of 2643 pediatric patients were included in the 33 studies. LIMITATIONS: Management is largely informed by clinical practices in adult patients with scant data on treatment efficacy in children. CONCLUSIONS: The reported incidence of disorders of the pouch in children varies widely and is likely attributable to differences in definitions and follow-up periods across studies. Pouchitis was the most frequently described outcome. The overall rate of pouch failure in children is relatively low, with de novo Crohn's disease of the pouch being the most significant risk factor. Multicenter prospective studies are needed in the pediatric population to accurately identify risk factors, standardize the assessment of pouch complications, and determine effective treatment strategies. See video from the symposium .


Subject(s)
Pouchitis , Proctocolectomy, Restorative , Humans , Proctocolectomy, Restorative/adverse effects , Proctocolectomy, Restorative/methods , Child , Pouchitis/diagnosis , Pouchitis/therapy , Pouchitis/etiology , Postoperative Complications/diagnosis , Postoperative Complications/epidemiology , Colonic Pouches/adverse effects , Colitis, Ulcerative/surgery , Colitis, Ulcerative/diagnosis , Colitis, Ulcerative/therapy , Adenomatous Polyposis Coli/surgery , Adenomatous Polyposis Coli/diagnosis , Anastomotic Leak/diagnosis , Anastomotic Leak/etiology , Anastomotic Leak/epidemiology , Anastomotic Leak/therapy , Crohn Disease/diagnosis , Crohn Disease/surgery , Crohn Disease/therapy , Crohn Disease/complications
2.
Neurogastroenterol Motil ; 34(7): e14314, 2022 07.
Article in English | MEDLINE | ID: mdl-34984765

ABSTRACT

BACKGROUND: Autoimmune gastrointestinal dysmotility (AGID) is a limited form of dysautonomia that can be paraneoplastic or idiopathic. Some presentations can be preceded by a viral infection. METHODS: We report a case of a 17-year-old girl that developed intractable nausea and early satiety after SARS-CoV-2 infection. KEY RESULTS: Over ten months, she required nasogastric and nasoduodenal tube feedings and finally was advanced to total parenteral nutrition to meet her caloric needs. Her α3 nicotinic ganglionic acetylcholine and anti-striational antibodies were mildly elevated. Gastrointestinal transit scintigraphy studies showed delayed gastric emptying and slowed small bowel transit. Thermoregulatory sweat test showed areas of anhidrosis consistent with autonomic sudomotor impairment. After IVIG treatment the patient's symptoms improved dramatically and she was able to tolerate full oral diet. This was reflected by improvement of her baseline transit studies and the thermoregulatory sweat test. CONCLUSIONS AND INFERENCES: This is the first report of AGID occurring after SARS-CoV-2 infection. The dramatic response to IVIG emphasizes the importance of early recognition and the reversible and treatable nature of this condition.


Subject(s)
Autoimmune Diseases , COVID-19 , Gastrointestinal Diseases , Immunoglobulins, Intravenous , Adolescent , Autoantibodies , COVID-19/complications , Female , Gastrointestinal Diseases/immunology , Gastrointestinal Transit , Humans , SARS-CoV-2
SELECTION OF CITATIONS
SEARCH DETAIL
...